Cost sharing for substance abuse and mental health services in managed care plans
Abstract
Recent initiatives to improve private insurance coverage for substance abuse and mental health in the United States have mostly focused on equalizing coverage limits to those found in general medical care. Federal law does not address cost sharing (copayments and coinsurance), which may also deter needed care or impose significant financial burdens on enrollees. This article reports on cost sharing requirements for outpatient care in a nationally representative sample of managed care plans in 1999. Levels of cost sharing are substantial, with around 40 percent of products requiring copayments of $20 or more and another 15 percent requiring coinsurance of 50 percent. Cost sharing for outpatient substance abuse treatment is very similar to that for mental health. Compared to general medical care, at least 30 percent of products impose higher cost sharing for substance abuse and mental health treatment. Future parity initiatives should be examined for how they address differences in cost sharing as well as limits.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Behavioral health insurance benefits have historically been less generous than insurance benefits for medical and surgical care in the employer-sponsored insurance market.
“Despite the fact that health insurance is supposed to protect individuals from financial shocks associated with healthcare expenses, behavioral health (BH) insurance benefits, which cover MH and SUD services, have historically been less generous than insurance benefits for medical and surgical care in the employer-sponsored insurance market (Barry et al., 2003; Hodgkin, Horgan, Garnick, & Merrick,”
From The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral healthcare utilization and spending among enrollees with substance use disorders (2017) · cites this paper as Hodgkin, Horgan, Garnick, & Merrick, 2003
Cited by
Sorted by citations
Ettner, S. L., M. Harwood, J., Thalmayer, A., Ong, M. K., Xu, H., Bresolin, M. J., Wells, K. B., Tseng, C.-H., & Azocar, F. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.09.009 · Cited by 53 · see citing works
Harwood, J. M., Azocar, F., Thalmayer, A., Xu, H., Ong, M. K., Tseng, C.-H., Wells, K. B., Friedman, S., & Ettner, S. L. (2017) · Medical Care · doi:10.1097/mlr.0000000000000635 · Cited by 28 · see citing works
Satre, D. D., Palzes, V. A., Young-Wolff, K. C., Parthasarathy, S., Weisner, C., Guydish, J., & Campbell, C. I. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108097 · Cited by 22 · see citing works
“price-sensitive relative to other medical care (Hodgkin et al., 2003; Parthasarathy & Campbell, 2016; Swartz, 2010), or not being aware of the implications of deductibles.”
BackgroundFriedman, S., Xu, H., Harwood, J. M., Azocar, F., Hurley, B., & Ettner, S. L. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.06.006 · Cited by 14 · see citing works
- Authors
- Hodgkin, D., Horgan, C. M., Garnick, D. W., & Merrick, E. L.
- Affiliations
- Brandeis University (US)
- Venue
- Medical Care Research and Review
- Publisher
- SAGE Publications
- Published
- 2003-03
- Volume
- 60
- Issue
- 1
- Pages
- 101-116
- ISSN
- 1077-5587 (ISSN-L)
- 1552-6801
- OpenAlex
- W2126226958
- Cited by
- 21
- References
- 0
- Citations by year
- 2021: 1 · 2020: 1 · 2017: 1 · 2016: 4
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medical Care Research and Review (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (R01AA010869)
- National Institute on Drug Abuse (R01DA010915)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Social Sciences › Economics, Econometrics and Finance › Finance › Healthcare Systems and Reforms
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- cost sharing, copayments, coinsurance, addiction treatment, mental health services, managed care plans, outpatient care, private health insurance, coverage limits, financial burden of care
- MeSH terms
- Mental Disorders, Humans, Managed Care Programs, Mental Health Services, United States, Cost Sharing, Cost of Illness, Health Care Surveys, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review